Metro Healthcare Berhad (KLSE:METRO)

Metro Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	50.52	50.42	48.65	44.69	40.27	42.26
Revenue Growth (YoY)	6.30%	3.63%	8.87%	10.96%	-4.70%	49.14%
Cost of Revenue	31.48	31.46	28.92	26.61	24.27	22.16
Gross Profit	19.04	18.96	19.73	18.08	16.01	20.09
Other Operating Expenses	11.56	12.02	12.32	9.21	8.71	8.11
Operating Expenses	11.56	12.02	12.32	9.21	8.71	8.11
Operating Income	7.48	6.94	7.4	8.87	7.3	11.98
Interest Expense	-0.63	-0.62	-0.69	-0.73	-0.4	-0.37
Interest & Investment Income	1.64	1.64	0.46	0.21	0.17	0.11
EBT Excluding Unusual Items	8.49	7.96	7.17	8.35	7.07	11.72
Gain (Loss) on Sale of Investments	0.02	0.02	-	-	0.08	0.79
Gain (Loss) on Sale of Assets	0.02	0.02	-	0.03	0.22	0.02
Other Unusual Items	0.16	0.16	-	0.16	0	0.07
Pretax Income	8.69	8.17	7.17	8.54	7.38	12.6
Income Tax Expense	2.14	2.31	2.61	2.29	2.36	3.17
Net Income	6.56	5.86	4.56	6.25	5.02	9.44
Net Income to Common	6.56	5.86	4.56	6.25	5.02	9.44
Net Income Growth	111.64%	28.56%	-27.02%	24.56%	-46.85%	72.32%
Shares Outstanding (Basic)	979	979	979	822	822	822
Shares Outstanding (Diluted)	979	979	979	822	827	822
Shares Change (YoY)	-3.85%	-	19.05%	-0.55%	0.55%	1.82%
EPS (Basic)	0.01	0.01	0.00	0.01	0.01	0.01
EPS (Diluted)	0.01	0.01	0.00	0.01	0.01	0.01
EPS Growth	120.15%	28.56%	-38.70%	24.56%	-46.86%	69.25%
Free Cash Flow	8.06	7.59	5.58	7.38	4.67	7.21
Free Cash Flow Per Share	0.01	0.01	0.01	0.01	0.01	0.01
Dividend Per Share	0.005	0.006	0.005	0.005	0.005	0.002
Dividend Growth	-25.37%	20.37%	1.89%	6.00%	212.50%	6.67%
Gross Margin	37.68%	37.61%	40.55%	40.46%	39.74%	47.55%
Operating Margin	14.80%	13.77%	15.22%	19.85%	18.12%	28.36%
Profit Margin	12.98%	11.63%	9.37%	13.98%	12.46%	22.33%
Free Cash Flow Margin	15.96%	15.06%	11.46%	16.52%	11.60%	17.05%
EBITDA	10.91	10.37	10.62	11.66	9.97	13.99
EBITDA Margin	21.59%	20.57%	21.84%	26.10%	24.76%	33.10%
D&A For EBITDA	3.43	3.43	3.22	2.79	2.68	2.01
EBIT	7.48	6.94	7.4	8.87	7.3	11.98
EBIT Margin	14.80%	13.77%	15.22%	19.85%	18.12%	28.36%
Effective Tax Rate	24.59%	28.25%	36.43%	26.86%	32.01%	25.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error